… Duodenopancreatic neuroendocrine neoplasias (DP-NENs) are still the … treatment.
Especially over the last 2 years, more clinical experience has documented the follow-up of treated …

… Advances and modifications in the treatment of advanced metastatic disease is only briefly
… As in the previous functional pancreatic neuroendocrine tumor (FP-NET) guidelines [1], the …

… NEN can be termed functioning in the presence of clinical symptoms of hormonal hypersecretion
or non-functioning where symptoms, if present, may relate purely to tumour mass. In …

… and neoplastic neuroendocrine cells. Most commonly assessed neuroendocrine antigens are
… Regulators of cell function Identification of neuroendocrine differentiation and potential for …

… A variety of prognostic or treatment-related biomarkers (ie CK19) has been investigated, … al
and may be performed in order to establish functional activity, help to find the primary (in case …

… The treatment of functioning pancreatic neuroendocrine tumors (FpNETs) has at least two
goals; one to control the clinical symptoms and the hormone excess but also the tumor growths…

… Neuroendocrine tumors represent a group of neoplasias … The basic study of the biological
features of neuroendocrine … for either well-differentiated or functioning tumors. On the other …

… The treatment of patients with functional symptoms should aim primarily in reducing the …
the context of multiple endocrine neoplasia type 1 (MEN1) syndrome [5] [70]. Patients should be …

… Long-acting somatostatin analogs constitute the main treatment for the majority of functioning
tumors, whereas specific evolving agents such as telotristat may be used for the control of …

… Recent improvements in both morphologic and functional imaging … functional imaging
techniques are useful both for detection and prognostic evaluation and can change treatment …